PHR Company Profile and Key Details

Q: Who are the executives of PHR?

Mr. Evan RobertsCo-Founder & Chief Operating OfficerMr. Balaji GandhiSenior Vice President of Investor RelationsMr. Michael J. DavidoffSenior Vice President of Payer SolutionsMr. Randy RasmussenChief Financial OfficerMr. Daniel NathanChief Technology OfficerMr. David LinetskySenior Vice President of Life SciencesMs. Kharen HauckVice President of MarketingMs. Maureen McKinneyVice President of Corporation CommunicationsMs. Allison C. HoffmanGen. Counsel & Sec.Ms. Amy Beth VanDuynSenior Vice President of HRMs. Janet M. GunzburgVice President, Principal Accounting Officer & ControllerMr. Chaim IndigCo-Founder, Chief Executive Officer & Director

NYSE : PHR

Phreesia

$9.08

0.31+3.53%

At Close 4:00 PM

59.85

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Phreesia, Inc. (PHR) stock surged +3.53%, trading at $9.08 on NYSE, up from the previous close of $8.77. The stock opened at $8.85, fluctuating between $8.76 and $9.22 in the recent session.

Stock Snapshot

8.77

Prev. Close

560.91M

Market Cap

8.76

Day Low

227

P/E Ratio

0.04

EPS (TTM)

-1.05

Cash Flow per Share

8.85

Open

61.77M

Number of Shares

9.22

Day High

89.4%

Free Float in %

4.61

Book Value

1.4M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 18, 2026	8.85	9.22	8.75	9.08	1.71M
May 15, 2026	8.59	9.04	8.59	8.77	1.55M
May 14, 2026	9.12	9.26	8.64	8.77	1.88M
May 13, 2026	9.44	9.57	8.98	9.19	1.14M
May 12, 2026	9.50	9.68	9.42	9.61	1.05M
May 11, 2026	10.10	10.21	9.50	9.57	1.01M
May 08, 2026	9.71	10.27	9.63	10.17	1.03M
May 07, 2026	9.59	10.05	9.56	9.83	1.38M
May 06, 2026	9.57	9.57	9.34	9.53	977.64K
May 05, 2026	9.55	9.71	9.43	9.65	960.36K
May 04, 2026	9.69	9.93	9.55	9.67	1.02M
Apr 30, 2026	9.20	9.24	8.85	9.21	1.31M
Apr 29, 2026	9.38	9.40	9.13	9.37	899.66K
Apr 28, 2026	9.67	9.91	9.36	9.42	1.02M
Apr 27, 2026	9.49	9.78	9.46	9.62	1.61M
Apr 23, 2026	9.20	9.20	8.72	8.85	1.42M
Apr 22, 2026	9.35	9.56	9.22	9.32	1.25M
Apr 21, 2026	9.50	9.86	9.32	9.36	1.28M
Apr 20, 2026	9.06	9.46	9.00	9.43	1.44M
Apr 17, 2026	9.28	9.50	9.13	9.17	1.6M

Contact Details

Wilmington, NC 27601

United States

https://www.phreesia.com 888 654 7473

About Company

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Stock Peers

VEEV

4.995+3.14%

Veeva Systems Inc.$163.85 HNGE

0.21+0.39%

Hinge Health, Inc.$54.71 MPLN

-0.36-1.53%

MultiPlan Corporation$23.15 DOCS

0.61+3.22%

Doximity, Inc.$19.58 CTEV

2.55+18.39%

Claritev Corporation$16.42 AGTI

-0.05-0.50%

Agiliti, Inc.$10.05 AMWL

0.19+2.51%

American Well Corporation$7.76 TDOC

-0.01-0.16%

Teladoc Health, Inc.$6.35 EVH

-0.06-1.52%

Evolent Health, Inc.$3.90 UPH

0.0251+9.13%

UpHealth, Inc.$0.30

Company Overview

Phreesia, Inc. (NYSE:PHR) closed at $9.08 USD, gaining $0.31 (3.53%) from the previous close of $8.77. The stock is currently mid-range between its 52-week high and low $7.77 and $32.76. With a market capitalization of about $560.91 million, Phreesia, Inc. is classified as a small-cap and shows market-like volatility (beta ~0.89). Key stats such as the average daily volume over the past year has been around 1.92 million shares, in line with its 52-week average. Headquartered in Wilmington, NC, Phreesia, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Chaim Indig, the company employs approximately 2,082 people and listed since July 18, 2019. Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -0.83%, SMA50 -16.98%, SMA200 -45.07%). The stock’s 14-day RSI is 39.06 (weak momentum), while the ATR of 0.67 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -62.36% below its high and over 9.02% above its low. Average 10-day trading volume of 1.39 million shares is below the 3-month average of 1.94 million, indicating normal recent market interest.

Valuation Metrics

Phreesia, Inc. trades at a P/E ratio of 235.48, slightly above the S&P 500 average, with a price-to-sales ratio of 1.15 and a price-to-book ratio of 1.61 suggesting the stock is closer to book value. The P/FCF stands at 8.65, also above market averages.

Dividend & Fair Value

Phreesia, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $31.33. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Phreesia, Inc. generated EPS of -$0.10 over the past year. Five-year average earnings growth is 16.05%. The latest quarter delivered EPS of $0.12. The next quarter is forecast at $0.07. Next year's EPS is expected at $43.20. Analyst sentiment is bullish. Analyst rating data shows there are 19 Strong Buy ratings, 13 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $38.00 to $10.00. The high target offers 318.5% upside. The low target suggests 10.13% downside. The mean target is $27.19. This offers 199.45% upside. Phreesia, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended March 30, 2026, missed forecasts by 82.62%. The prior quarter beat by -71.06%. Over the last six quarters, Apple has recorded several small beats. These include -7.41% in December 09, 2024.

Shareholding & Insider Activity

Phreesia, Inc. has 59.91 million shares outstanding. The public float is 53.57 million shares, elevated short interest at 5.13% of float. This equals 2.94 million shares. The short ratio is 4.09 days. Institutional investors hold 104.21% of the float. Insiders own 4.19%. Pale Fire Capital SE holds 8.92 million shares, Indig Chaim has 1.36 million shares and Roberts Evan has 826.55 thousand shares. Over the past six months, insider transactions show net selling. They sold 132.33 thousand shares across 31 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Phreesia generated $480.59M in revenue, or $7.82 per share. Gross margin was 61.27%, operating margin 0.54%, and net profit margin 0.48%. Returns are modest, with ROA at 0.35% and ROE at 0.68%.
On valuation metrics, Phreesia trades at a P/E of 235.48, P/S of 1.15 and P/B of 1.61. The current ratio is 1.53 and quick ratio is 1.53. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 94.93 days. Debt-to-equity is 0.30, supported by a cash flow-to-debt ratio of 0.77.

Quarterly Financial Highlights

For the quarter ended Jan 31, 2026, Phreesia posted revenue of $480.59M, down slightly from $419.81M in the prior quarter. Gross profit was $294.45M (margin 61.27%). Operating income was $2.61M (margin 0.5%). Net income was$2.31M (EPS $0.04).
The company ended the quarter with $73.83M in cash and short-term investments, a total debt of $102.45M, and net debt of $28.62M. Total assets were $663.79M, with equity of $337.21M. Financials further reflected stability, with operating cash flow of $78.81M, free cash flow of $67.71M, and capital expenditures of - $11.10M.

Price Forecast & Outlook

Our AI price prediction model suggests that Phreesia, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.88%, with price expected at $9.16 by June 01, 2026, within a range of $8.31 to $10.09 3-Month Outlook: Projected fall of -21.37%, reaching $7.14 by August 14, 2026, with a range of $6.38 to $7.77. 1-Year Outlook: Projected loss of -99.78%, with price at $0.02 by May 18, 2027, within a range of $0.00 to $1.64.

Key Takeaways

Phreesia, Inc. (NYSE:PHR) shares are flat -7.03% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Phreesia, Inc. trading at a premium to the broader market with a P/E of 235.48. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $34.65, suggesting 281.61% upside. Our AI forecast model points to short-term strength (0.88% over two weeks), a medium-term fall (-21.37% over three months), and a longer-term loss (-99.78% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Phreesia, Inc. (PHR) stock price?

Phreesia, Inc. (NYSE: PHR) stock price is $9.08 in the last trading session. During the trading session, PHR stock reached the peak price of $9.22 while $8.76 was the lowest point it dropped to. The percentage change in PHR stock occurred in the recent session was 3.53% while the dollar amount for the price change in PHR stock was $0.31.

PHR's industry and sector of operation?

The NYSE listed PHR is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Phreesia, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PHR?

Mr. Evan Roberts
Co-Founder & Chief Operating Officer
Mr. Balaji Gandhi
Senior Vice President of Investor Relations
Mr. Michael J. Davidoff
Senior Vice President of Payer Solutions
Mr. Randy Rasmussen
Chief Financial Officer
Mr. Daniel Nathan
Chief Technology Officer
Mr. David Linetsky
Senior Vice President of Life Sciences
Ms. Kharen Hauck
Vice President of Marketing
Ms. Maureen McKinney
Vice President of Corporation Communications
Ms. Allison C. Hoffman
Gen. Counsel & Sec.
Ms. Amy Beth VanDuyn
Senior Vice President of HR
Ms. Janet M. Gunzburg
Vice President, Principal Accounting Officer & Controller
Mr. Chaim Indig
Co-Founder, Chief Executive Officer & Director

How PHR did perform over past 52-week?

PHR's closing price is 16.86% higher than its 52-week low of $7.77 where as its distance from 52-week high of $32.76 is -72.28%.

How many employees does PHR have?

Number of PHR employees currently stands at 2,082.

Link for PHR official website?

Official Website of PHR is: https://www.phreesia.com

How do I contact PHR?

PHR could be contacted at phone 888 654 7473 and can also be accessed through its website. PHR operates from 434 Fayetteville Street, Wilmington, NC 27601, United States.

How many shares of PHR are traded daily?

PHR stock volume for the day was 1.4M shares. The average number of PHR shares traded daily for last 3 months was 1.92M.

What is the market cap of PHR currently?

The market value of PHR currently stands at $560.91M with its latest stock price at $9.08 and 61.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2082
Beta	0.85
Sales or Revenue	$480.59M
5Y Sales Change%	1.138%
Fiscal Year Ends	January
Sector	Healthcare
Industry	Medical - Healthcare Information Services

PHR Company Profile and Key Details

Phreesia

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Valuation Metrics

Price Forecast & Outlook

Key Takeaways